Conditions

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …

How early is too early?

David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control In 2003, the Treat to Target Trial study results were published. The study compared the effectiveness of a patient mediated titration schedule with both NPH and glargine, and also whether patient titration was as good as a prescriber-based titration….

The link between high blood glucose, blood vessel damage, and Alzheimer’s…. 

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD INTRODUCTION Normal Physiology The normal pancreas deftly releases basal insulin, superimposed with bursts of insulin for rising glucose levels associated …

Proportions may be the key…. 

Implanting encapsulated beta cells may be beneficial…. 

Islet transplantation helps correct hyperglycemia….

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Andrew M. Posselt, MD, PhD, FACS, and Peter Stock, MD, PhD Follow this link for Part 1: Beta-Cell Replacement (See also our recent interview on the use of pig islets in Phase 3 trials with …

New technology finds working beta cells in pancreas….